Inventor · disambiguated record
Mark Balasovski
Also filed as: BALASOVSKI MARK B
3 granted patents·4 pending applications·52 citations·filing 1999–2008
72Inventor score
Files withNOVELOS THERAPEUTICS INC5
Top patents by PatentIndex Score
7 records- 0184US7371411B2Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cellsNOVELOS THERAPEUTICS INC·Filed 2006·Granted May 13, 2008·4 cites·20 claims
- 0277US7169412B2Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cellsNOVELOS THERAPEUTICS INC·Filed 2003·Granted Jan 30, 2007·15 cites·126 claims
- 0371US6312734B1Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cellsNOVELOS THERAPEUTICS INC·Filed 1999·Granted Nov 6, 2001·33 cites·136 claims
- 0463US2007142267A1Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cellsNOVELOS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0558US2008220093A1Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cellsNOVELOS THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 0651US2003077334A1Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanism for normal and transformed cellsFiled 2001·Application pending·0 cites
- 0751US2002016288A1Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cellsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Balasovski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →